NEW YORK (Reuters Health) – Diabetes incidence falls during rosiglitazone treatment but returns to baseline after rosiglitazone withdrawal, according to the preprint version of a study that is…
NEW YORK (Reuters Health) – Patients with type 2 diabetes without retinopathy can be safely screened for sight-threatening vision problems every 3 years instead of every 1 or…
NEW YORK (Reuters Health) – For patients with idiopathic sudden sensorineural hearing loss, intratympanic injection of corticosteroids is no better or worse than oral corticosteroid therapy, but is…
NEW YORK (Reuters Health) – The use of inhaled anticholinergic drugs to treat chronic obstructive pulmonary disease (COPD) is associated with an increased risk of developing urinary retention…
NEW YORK (Reuters Health) – Results of a meta-analysis confirm that the oral tyrosine kinase inhibitor gefitinib is effective as first-line therapy in patients with advanced non-small-cell lung…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses the risk of cardiovascular disease among women and how to prevent…
Joseph Ramagnulo, MD, MSc, FRCPC, Associate Professor Gastroenterology and Hepatology, Medical University of South Carolina, discusses pancreatic stenting in high risk patients who undergo ERCP. This procedure reduces…
Joseph Ramagnulo, MD, MSc, FRCPC, Associate Professor Gastroenterology and Hepatology, Medical University of South Carolina, discusses different types of cases requiring sphincterotomy to reduce pain. Related ReadingMeasuring episodic…
NEW YORK (Reuters Health) – The estimated 10-year risk for coronary heart disease (CHD) among adults with diabetes has declined significantly in the past decade, according to a…
NEW YORK (Reuter Health) – Among postmenopausal women with overactive bladder, an ultra-low-dose estradiol-releasing vaginal ring is as effective as oral oxybutynin in reducing voiding frequency, a team…
